AdvaMed Announces Formation of Medical Imaging Division

World’s largest medical imaging companies join world’s largest medtech association WASHINGTON, D.C., – Today, AdvaMed, the Medtech Association, announced the establishment of a new Medical Imaging Technology division focused on advocating on behalf of large and small companies for the essential role of medical imaging technology, radiopharmaceuticals, contrast media, and focused ultrasound devices in our nation’s health care…

Read More

Emory, Georgia Tech & Children’s Healthcare land major NIH grant for diagnostics

The National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health has awarded $7.8 million over the next five years to the Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT) to support inventors across the country in developing, translating and testing microsystems-based point-of-care technologies to help improve patient care. Point-of-care technologies…

Read More

Lucid Scientific Secures $7 Million Series A Financing Led by IAG Capital Partners

Maker of continuous real-time metabolic analysis systems experiences growing demand. Will build capacity for new product offerings, manufacturing, and global sales and marketing. September 26, 2023 05:42 PM Eastern Daylight Time ATLANTA–(BUSINESS WIRE)–Lucid Scientific, a life science instruments company that manufactures Resipher, announced the completion of a $7 million Series A financing led by IAG…

Read More

Sanguina Raises $2.8M in Series A Funding to Drive Innovation in Home-Based Testing and Wellness Management

PEACHTREE CORNERS, Ga.–(BUSINESS WIRE)–Sanguina, a leading biotech company focused on providing rapid home-based testing and management solutions, announced today the successful completion of its $2.8m Series A funding round. Led by Veritus Holdings, the round saw participation from notable investors, including George Hornig of The Seed Lab and Stephen Ippolito of Veritus Holdings. The funding will be…

Read More

Acadia Pharmaceuticals Announces Phase 3 Development Candidate ACP-101 (intranasal carbetocin) for Prader-Willi Syndrome

— Acadia acquired Levo Therapeutics and worldwide rights to ACP-101 in June 2022 — ACP-101 (intranasal carbetocin) is a selective oxytocin-receptor agonist for the treatment of hyperphagia in Prader-Willi syndrome — Company recently completed a meeting with the FDA and plans to initiate a Phase 3 study in the fourth quarter of 2023 — Webcast…

Read More